Listen Score
LS 30
Global Rank
TOP 5%

ABOUT THIS PODCAST 🔗

Average audio length:
42 minutes
English
United States
56 episodes
since Feb. 20, 2008
episodic

LATEST EPISODE 🔗

Frank McCormick discusses how each protein is a problem in the use of pharmaceutics to combat cancer and suggests that developing a platform that can be used for anything is the process that will alter the future of cancer treatment. (September 16, 2008)

SEARCH PAST EPISODES

Search past episodes of Comprehensive Cancer Research Training Program.

PREVIOUS EPISODES

Anthony Oro, MD, PhD, discusses how Hedgehog signally is a model for a variety of morphogenetic signals, that taking stem cells to effect wound healing may have an important role in pathogenesis. (September 16, 2008)
Dr. Saul Rosenberg discusses the history of diagnosis and treatment of Hodgkin's Disease and the remarkable improvement in curability since the 1960's. (September 15, 2008)
Stanford's Branimir Sikic discusses the importance of, and offers guidance to achieve the development of personalized medicines that are risk adapted genomic guided therapies which make a major impact on the disease. (September 15, 2008)
Dr. Michael Cleary discusses this work on the role of chromosomal aberrations in causing cancer and its implications for cancer treatment. (September 18, 2008)
Dr. John K. Chan, gyncecologic cancer specialist at the University of California - San Francisco Medical Center, discusses recent advances in the study of gynecologic cancers, focusing on novel therapeutics in ovarian cancer. (September 18, 2009)
Dr. Linda M. Boxer discusses her research on acute leukemia. (September 18, 2008)
Dr. James Brooks discusses his work on screening for and treatment of prostate cancer. (September 18, 2008)
Professor Christopher Contag discusses immune cell trafficking patterns as they relate to recognition of minimal residual disease. (September 16, 2008)
Dr. James Ford, Associate Professor of Medicine and Genetics at the Stanford University School of Medicine, discusses possibilities for using genetic testing to predict and manage the risks of certain cancers. (September 17, 2008)
Disclaimer: The podcast and artwork embedded on this page are from Stanford University, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.